State Street’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.6K | Hold |
12,146
| – | – | ﹤0.01% | 4085 |
|
|
2025
Q1 | $34.5K | Hold |
12,146
| – | – | ﹤0.01% | 4143 |
|
|
2024
Q4 | $71.9K | Hold |
12,146
| – | – | ﹤0.01% | 4059 |
|
|
2024
Q3 | $34K | Hold |
12,146
| – | – | ﹤0.01% | 4162 |
|
|
2024
Q2 | $38.3K | Hold |
12,146
| – | – | ﹤0.01% | 4191 |
|
|
2024
Q1 | $26.4K | Hold |
12,146
| – | – | ﹤0.01% | 4256 |
|
|
2023
Q4 | $36.8K | Hold |
12,146
| – | – | ﹤0.01% | 4255 |
|
|
2023
Q3 | $40.3K | Hold |
12,146
| – | – | ﹤0.01% | 4335 |
|
|
2023
Q2 | $47.1K | Hold |
12,146
| – | – | ﹤0.01% | 4434 |
|
|
2023
Q1 | $90.7K | Buy |
12,146
+9,601
| +377% | +$71.7K | ﹤0.01% | 4346 |
|
|
2022
Q4 | $27.6K | Sell |
2,545
-3
| -0.1% | -$33 | ﹤0.01% | 4680 |
|
|
2022
Q3 | $54K | Hold |
2,548
| – | – | ﹤0.01% | 4640 |
|
|
2022
Q2 | $102K | Buy |
2,548
+63
| +3% | +$2.52K | ﹤0.01% | 4529 |
|
|
2022
Q1 | $139K | Buy |
2,485
+1,079
| +77% | +$60.4K | ﹤0.01% | 4521 |
|
|
2021
Q4 | $58K | Hold |
1,406
| – | – | ﹤0.01% | 4673 |
|
|
2021
Q3 | $116K | Buy |
1,406
+498
| +55% | +$41.1K | ﹤0.01% | 4509 |
|
|
2021
Q2 | $108K | Buy |
+908
| New | +$108K | ﹤0.01% | 4347 |
|